Scope
Reference
PHA - FTS - 61334 USTEKINUMAB
Description
Supply of Ustekinumab to NHS Wales.
Total value (estimated)
- £9,489,301 excluding VAT
- £11,387,161 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 October 2026 to 30 June 2028
- Possible extension to 30 June 2029
- 2 years, 9 months
Description of possible extension:
12 month extension option available.
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKL - Wales
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Enquiry deadline
6 March 2026, 12:00am
Tender submission deadline
9 March 2026, 10:00am
Submission address and any special instructions
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
10 June 2026
Award criteria
| Name | Type | Order of importance |
|---|---|---|
| Product quality/acceptability | Quality | 1 |
| Financial (overall cost of contract) | Price | 2 |
| Environmental/Social Value/Community Benefits | Quality | 3 |
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS Organisation Data Service: RQF
4-5 Charnwood Court,
Cardiff
CF14 3UZ
United Kingdom
Contact name: Caroline Cheng
Email: caroline.cheng2@wales.nhs.uk
Region: UKL22 - Cardiff and Vale of Glamorgan
Organisation type: Public authority - central government
Devolved regulations that apply: Wales